Real-time enrollment status for this bladder carcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:36 AM UTC
| NCT Number | NCT05059444 |
| Recruiting Status | Recruiting |
| Condition | Bladder Carcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 2,020 participants |
| Active Locations | 33 sites in the US |
| Sponsor | Guardant Health, Inc. |
| Last Updated on CT.gov | August 22, 2025 (Aug 22, 2025) |
As of July 13, 2026: Clinical trial NCT05059444 is currently recruiting participants. This clinical trial study for bladder carcinoma is actively seeking new participants at 33 locations across the United States. The study is sponsored by Guardant Health, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05059444 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 33 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05059444 was last updated Aug 22, 2025 (August 22, 2025). HelloStudys verifies this status automatically.